Transmission of oxLDL-derived lipid peroxide radicals into membranes of vascular cells is the main inducer of oxLDL-mediated oxidative stress

Atherosclerosis

Volumn 197, Issue 2, 2008, Pages 602-611

  Hansen Hagge, Thomas E ^a   Baumeister, Elke ^a   Bauer, Tanja ^a   Schmiedeke, Daniel ^a   Renné, Thomas ^a   Wanner, Christoph ^a   Galle, Jan ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

Inflammation; Metabolic disease; Oxidative stress; Oxidized low density lipoprotein; Reactive oxygen species; Vascular cells

Indexed keywords

4,4 DIFLUORO 5 (4 PHENYL 1,3 BUTADIENYL) 4 BORA 3A,4A DIAZA S INDACENE 3 UNDECANE; 5 CARBOXY 2',7' DICHLORODIHYDROFLUORESCEIN DIACETATE; 6 CARBOXY 2',7' DICHLORODIHYDROFLUORESCEIN DIACETATE; ACETYL LOW DENSITY LIPOPROTEIN; CARBON 11; CATALASE; DEFERIPRONE; DIHYDROETHIDINE; DIMETHYL SULFOXIDE; DIMETHYLTHIOUREA; FATTY ACID DERIVATIVE; FLUORESCENT DYE; LIPID PEROXIDE; LOW DENSITY LIPOPROTEIN; N(G) NITROARGININE METHYL ESTER; OXIDIZED LOW DENSITY LIPOPROTEIN; OXYETHIDINE; OXYGEN; PEROXY RADICAL; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE; SCAVENGER; SUPEROXIDE DISMUTASE; UNCLASSIFIED DRUG;

ARTERY MUSCLE; ARTICLE; ATHEROGENESIS; BLOOD VESSEL; CARDIOVASCULAR DISEASE; CELL CULTURE; CELL MEMBRANE; CELL STRESS; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME ACTIVATION; FLUORESCENCE; HUMAN; HUMAN CELL; INFLAMMATION; INTRACELLULAR SPACE; LIPID TRANSPORT; METABOLIC DISORDER; MITOSIS; MUSCLE CELL; NORMAL HUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; TREATMENT PLANNING;

CELL MEMBRANE; CELLS, CULTURED; ENDOTHELIAL CELLS; HUMANS; INFLAMMATION; LIPID PEROXIDES; LIPOPROTEINS, LDL; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES; UMBILICAL VEINS;

EID: 40949090475     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2007.08.029     Document Type: Article

References (24)

1. Stocker R., and Keaney Jr. J.F. Physiol Rev 84 (2004) 1381-1478
2. Galle J., and Seibold S. Nephrol Dial Transplant 18 (2003) 1452-1455
3. Madamanchi N.R., Hakim Z.S., and Runge M.S. J Thromb Haemost 3 (2005) 254-267
4. Galle J., Hansen-Hagge T., Wanner C., and Seibold S. Impact of oxidized low density lipoprotein on vascular cells. Atherosclerosis 185 2 (2006) 219-226
5. Seibold S., Schurle D., Heinloth A., Wolf G., Wagner M., and Galle J. J Am Soc Nephrol 15 (2004) 3026-3034
6. Yokoyama M., Inoue N., and Kawashima S. Ann NY Acad Sci 902 (2000) 241-247
7. Heinloth A., Heermeier K., Raff U., Wanner C., and Galle J. J Am Soc Nephrol 11 (2000) 1819-1825
8. Li D., and Mehta J.L. Arterioscler Thromb Vasc Biol 20 (2000) 1116-1122
9. Mehta J.L., Chen J., Hermonat P.L., Romeo F., and Novelli G. Cardiovasc Res 69 (2006) 36-45
10. Spiteller G. Ann NY Acad Sci 1043 (2005) 355-366
11. Jacobi J., Kristal B., Chezar J., Shaul S.M., and Sela S. Free Radic Biol Med 39 (2005) 1238-1248
12. Galle J., Mameghani A., Bolz S.S., et al. J Am Soc Nephrol 14 (2003) 1471-1479
13. Basu S.K., Goldstein J.L., Anderson G.W., and Brown M.S. Proc Natl Acad Sci USA 73 (1976) 3178-3182
14. Yeum K.J., Aldini G., Chung H.Y., Krinsky N.I., and Russell R.M. J Nutr 133 (2003) 2688-2691
15. Brandes R.P., and Janiszewski M. Kidney Int 67 (2005) 1662-1664
16. Myhre O., Andersen J.M., Aarnes H., and Fonnum F. Biochem Pharmacol 65 (2003) 1575-1582
17. Muzykantov V.R. J Control Release 71 (2001) 1-21
18. Chen X.L., Zhang Q., Zhao R., and Medford R.M. Am J Physiol Heart Circ Physiol 286 (2004) H1001-H1007
19. Pap E.H., Drummen G.P., Winter V.J., et al. FEBS Lett 453 (1999) 278-282
20. Ruan X.Z., Moorhead J.F., Tao J.L., et al. Arterioscler Thromb Vasc Biol 26 (2006) 1150-1155
21. Argmann C.A., Sawyez C.G., Li S., et al. Arterioscler Thromb Vasc Biol 24 (2004) 1290-1296
22. Sukhanov S., Higashi Y., Shai S.Y., et al. Circ Res (2006)
23. Afri M., Frimer A.A., and Cohen Y. Chem Phys Lipids 131 (2004) 123-133
24. Maziere C., Alimardani G., Dantin F., et al. FEBS Lett 448 (1999) 49-52